Transcriptional suppression of Sox9 expression in chondrocytes by retinoic acid


Autoria(s): Sekiya, I.; Koopman, P. A.; Tsuji, K.; Mertin, S.; Harley, V.; Yamada, Y.; Shinomiya, K.; Niguji, A.; Noda, M.
Data(s)

01/01/2001

Resumo

SOX9 is a transcription factor that is expressed in chondrocytes and regulates expression of chondrocyte phenotype related genes. Expression of these genes is known to be suppressed by retinoic acid (RA). We, therefore, examined whether the Sox9 gene expression is regulated by RA in chondrocytes. RA treatment suppressed Sox9 mRNA expression in primary chondrocytes prepared from newborn mouse rib cartilage within 12 h and this suppression lasted at least up to 24 h. The RA suppression of Sox9 mRNA levels was dose-dependent starting at 0.5 muM with a maximum at 1 muM. Nuclear run-on assays revealed that RA reduced the rate of transcription of Sox9 gene. Finally, Western blot analysis indicated that RA suppressed SOX9 protein revels in these chondrocytes. Furthermore, overexpression of SOX9 reversed RA suppression of Col/2a1 enhancer activity. These observations indicate that RA suppresses Sox9 gene expression in chondrocytes at least in part through transcriptional events. (C) 2001 Wiley-Liss, Inc.

Identificador

http://espace.library.uq.edu.au/view/UQ:61130

Idioma(s)

eng

Publicador

John Wiley & Sons Inc.

Palavras-Chave #Biochemistry & Molecular Biology #Cell Biology #SOX9 #chondrocyte #retinoic acid #transcription #type II collagen #Autosomal Sex Reversal #Sry-related Gene #Sensitive Protein Gene #Campomelic Dysplasia #Ii Collagen #Factor Ap-2 #Transgenic Mice #Mouse #Dna #Chondrogenesis #C1
Tipo

Journal Article